Discussion References How frequently are bedside glucose levels measured in hospital
inpatients on glucocorticoid treatment? Tab Page 1 Letters to the editor © Royal College of …

Objective To investigate the prevalence of and risk factors for hyperglycemia in hospitalized
patients receiving corticosteroids, which have been identified as an independent predictor of …

Background Glucocorticoid (GC)-induced hyperglycemia is a frequent adverse effect in
hospitalized patients. Guidelines recommend insulin treatment to a target range of 6–10 …

Objective: To compare the effectiveness of 2 insulin protocols to treat glucocorticoid-induced
hyperglycemia in the nonintensive care hospital setting. Methods: A randomized, open …

AIM: The objective of this study was to systematically evaluate the incidence of steroid-
induced hyperglycaemia in a tertiary referral hospital. We conducted a glucometric audit of a …

OBJECTIVE. The purpose of our study was to assess the glycemic risk of a 13-hour
corticosteroid premedication regimen in outpatients. MATERIALS AND METHODS. Clinical …

was 2.5 days (interquartile range [IQR] 1–4). Patients with SD had higher NEWS at
admission and higher peak NEWS during their hospitalisation (Table 1) but no difference in …

PREVIEW Although glucocorticoid therapy carries a risk of promoting or exacerbating
hyperglycemia, there are currently no established medical guidelines for detecting or …

Purpose Guidelines recommend systemic corticosteroids for acute exacerbation of chronic
obstructive pulmonary disease (AECOPD) albeit in lower doses than studies that cemented …

Purpose: To quantify risk for the occurrence of hyperglycemia requiring initiation of
hypoglycemic therapy in patients treated with oral glucocorticoids. Patients and Methods: A …